| 产品详情 |
| Edit |   |
|---|
| Product Name | Remogliflozin etabonate |
|---|
| Description | A prodrug form of remogliflozin A; inhibits human SGLT2 and SGLT1 (Kis = 1.95 and 43.1 µM, respectively); inhibits increases in plasma glucose levels in a glucose tolerance test in a rat model of STZ-induced diabetes at 3 and 10 mg/ml; increases fasting plasma insulin levels and reduces fasting plasma glucose and triglyceride levels, as well as urinary glucose excretion, in a db/db mouse model of diabetes with hyperinsulinemia and obesity at 10 and 30 mg/kg twice per day for 6 weeks |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | GSK 189075 |
|---|
| Gene, Accession, CAS # | CAS: 442201-24-3 |
|---|
| Catalog # | 14341-5 |
|---|
| Price | |
|---|
| Order / More Info | Remogliflozin etabonate from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|